The health and pharmaceuticals sector is one of the most important industries in the world. It plays a vital role in ensuring the health and wellbeing of people around the globe. The sector is also a major driver of economic growth, providing employment for millions of people worldwide.
The health and pharmaceuticals sector faced a number of challenges in 2020. These include the global pandemic, which has resulted in widespread disruption to healthcare systems; the increasing cost of drugs and medical treatments; and the challenges posed by new technologies such as artificial intelligence (AI). Despite these challenges, the health and pharmaceuticals sector expectedly grew significantly in 2020, with global sales forecast reaching $1.8 trillion.
Global pharmaceutical and healthcare companies face a range of challenges: disputes over intellectual property (IP), adherence to evolving government regulation and parallel trade challenges, to name only a few. Great opportunity exists as well. Growth is possible through strategic acquisitions, joint ventures, licensing, distribution, supply agreements and international trade.
The health and pharmaceuticals sector is facing a number of challenges, including the ongoing global pandemic and the increasing cost of drugs and medical treatments. Despite these challenges, the sector is expected to grow significantly this year, with global sales forecast to reach $1.8 trillion by the end of 2020. This growth will be driven by factors such as an aging population that will require more medical care, continued innovation in drug development, and increasing government investment in healthcare systems.
With our unique worldwide capabilities, including deep experience, we understand the business and legal intricacies that pharmaceutical and healthcare companies face on a daily basis. We work with many of the leading players in the pharmaceutical and healthcare sector on their dispute resolution, corporate and transactional needs (major financings, M&A transactions, litigation, etc.).
We advise pharmaceutical multinationals on the full range of IP, antitrust, commercial litigation and M&A issues across the Globe.